Euclidean Capital as of Sept. 30, 2023
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 12 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Gold Tr Gold Shs (GLD) | 39.8 | $182M | 1.1M | 171.45 | |
| Ishares Tr Msci India Etf (INDA) | 23.4 | $107M | 2.4M | 44.22 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 23.0 | $105M | 246k | 427.48 | |
| Pmv Pharmaceuticals (PMVP) | 3.5 | $16M | 2.6M | 6.14 | |
| Rapt Therapeutics (RAPT) | 2.4 | $11M | 658k | 16.62 | |
| 23andme Holding Class A Com (ME) | 2.2 | $10M | 10M | 0.98 | |
| Alector (ALEC) | 1.8 | $8.5M | 1.3M | 6.48 | |
| Foghorn Therapeutics (FHTX) | 1.7 | $7.9M | 1.6M | 5.00 | |
| Oric Pharmaceuticals (ORIC) | 1.3 | $6.0M | 989k | 6.05 | |
| Tenaya Therapeutics (TNYA) | 0.6 | $2.6M | 1.0M | 2.55 | |
| Ngm Biopharmaceuticals | 0.2 | $1.1M | 992k | 1.07 | |
| Surrozen | 0.1 | $394k | 803k | 0.49 |
